desogestrel has been researched along with Activated Protein C Resistance in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 8 (80.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al Dieri, R; Bloemen, S; Hemker, HC; Ten Cate, H; Ten Cate-Hoek, A | 1 |
Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC | 2 |
Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S | 1 |
Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG | 1 |
Skegg, DC | 1 |
Kluft, C | 1 |
Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC | 1 |
Curvers, J; Rosing, J; Tans, G | 1 |
1 review(s) available for desogestrel and Activated Protein C Resistance
Article | Year |
---|---|
Oral contraceptives, thrombosis and haemostasis.
Topics: Activated Protein C Resistance; Contraceptives, Oral; Desogestrel; Female; Hemostasis; Humans; Norpregnenes; Risk Factors; Venous Thrombosis | 2001 |
5 trial(s) available for desogestrel and Activated Protein C Resistance
Article | Year |
---|---|
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia | 2002 |
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis | 2005 |
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism | 1999 |
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia | 2000 |
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia | 2002 |
4 other study(ies) available for desogestrel and Activated Protein C Resistance
Article | Year |
---|---|
Procoagulant effect of vitamin K antagonists?
Topics: Activated Protein C Resistance; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; Humans; Lipoproteins; Protein S; Thrombophilia | 2011 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
Third generation oral contraceptives.
Topics: Activated Protein C Resistance; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Norpregnenes; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Thromboembolism | 2000 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |